Market Place
Sourcing Support
Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders
20 Sep 2022 //
SEEKING ALPHA
Syros and Tyme Technologies Announce Stockholder Approval of Merger
15 Sep 2022 //
BUSINESSWIRE
TYME Technologies, Inc. Announces Proxy Advisory Firms Glass Lewis and ISS
07 Sep 2022 //
GLOBENEWSWIRE
Syros Reports Second Quarter 2022 Financial Results
09 Aug 2022 //
BUSINESSWIRE
Syros buys Tyme, securing $190M to extend cash runway into 2025
06 Jul 2022 //
FIERCEBIOTECH
TYME Technologies Reports Q4 and Fiscal FY 2022 Financial Results
25 May 2022 //
GLOBENEWSWIRE
TYME Technologies, Inc. Announces Exploration of Strategic Options
29 Mar 2022 //
GLOBENEWSWIRE
TYME Technologies says SM-88 Poster at AACR
09 Mar 2022 //
GLOBENEWSWIRE
Microcap cancer player goes belly up after pancreatic tumor drug flops key study
27 Jan 2022 //
ENDPTS
TYME Announces Addn. PC Data on Effect of TYME-19 in SARS CoV-2 Infections
14 Dec 2021 //
BUSINESSWIRE
TYME Announces Dosing in Phase II OASIS Trial of Oral SM-88 in breast cancer
27 Sep 2021 //
BUSINESSWIRE
TYME Technologies Present at Upcoming Virtual Healthcare Industry Conferences
01 Sep 2021 //
BIO SPACE
Tyme Granted U.S. Patent Claims Covering Tyrosine-Based Drug Delivery Method
26 Jul 2021 //
BUSINESSWIRE
Tyme Technologies reports FY results
10 Jun 2021 //
SEEKING ALPHA
Tyme Technologies rises on pipeline update
10 Jun 2021 //
SEEKING ALPHA
Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial
10 Jun 2021 //
BUSINESSWIRE
TYME Announces Abstract Selected for Publication at the 2021 American Society
10 May 2021 //
BUSINESSWIRE
TYME Provides Business Update and Announces Third Quarter Fiscal 2021
04 Feb 2021 //
BUSINESSWIRE
Stock Alert: Tyme Technologies Soars 150%
03 Feb 2021 //
NASDAQ
TYME Granted U.S. Patent Claims Covering Use of TYME-19
03 Feb 2021 //
BUSINESSWIRE
TYME Announces SM-88 Abstract Selected for Presentation at the ASCO
09 Dec 2020 //
BUSINESSWIRE
TYME Builds Leadership Team with Announcement of New CEO
29 Nov 2020 //
BUSINESSWIRE
TYME’s Oncology Research Reveals Potential New Oral Therapy TYME-19
25 Aug 2020 //
BUSINESSWIRE
TYME Announces Outcome of Interim Futility Review for HopES Sarcoma PhII Study
10 Aug 2020 //
BUSINESSWIRE
TYME Announces Orphan Drug Designation for SM-88 as Potential Treatment
03 Aug 2020 //
BUSINESSWIRE
TYME-18 Demonstrates Anti-Cancer Effect in New Preclinical Data at AACR
23 Jun 2020 //
BIOSPACE
TYME Presents New Preclinical Data Supporting SM-88 MOA at AACR 2020
22 Jun 2020 //
BUSINESSWIRE
TYME Announces Abstracts Selected for Publication at the 2020 ASCO
28 May 2020 //
BUSINESSWIRE
TYME Announces Abstracts Selected for Publication at the 2020 ASCO
28 May 2020 //
BUSINESSWIRE
